by Lou | Jul 28, 2026 | Press Releases
CORE Biomedicine Signs Exclusive Licensing Agreement with Eisai for Precision Oncology Programs FollowFollow BOSTON, MA, USA and TOKYO, Japan — July 28, 2026 — CORE Biomedicine, an innovative drug discovery company developing next-generation precision medicines for...
by Lou | Jul 28, 2026 | Press Releases
CORE Biomedicine Secures $21 Million Series A Venture Financing and Receives AMED Grant Award to Advance Novel Cancer Therapeutics The venture financing and AMED grant funding position CORE to accelerate development of novel lineage-based oncology therapies for...
by Lou | Feb 19, 2026 | Fulfilled
JOB TITLE: Senior Scientist / Principal Investigator, Discovery Biology LOCATION: Boston, MA (On-site / Remote) FollowFollow Company Overview:CORE Biomedicine Inc. is a pioneering biotech startup dedicated to advancing novel therapies in oncology. We specialize in the...
by Lou | Feb 5, 2026 | Fulfilled
JOB TITLE: Director/Senior Director/VP, Drug Metabolism and Pharmacokinetics (DMPK/Clin Pharm) LOCATION: Boston, MA (On-site / Remote) FollowFollow Company Overview:CORE Biomedicine Inc. is a pioneering biotech startup dedicated to advancing novel therapies in...
by Lou | Jan 5, 2026 | Fulfilled
JOB TITLE: Senior Director/VP, Clinical Pharmacology LOCATION: Boston, MA (On-site / Remote) FollowFollow Company Overview:CORE Biomedicine Inc. is a pioneering biotech startup dedicated to advancing novel therapies in oncology. We specialize in the development of...
